Trial Profile
Randomized, Open-label Crossover Study to Evaluate Comparative Pharmacokinetics of Ibandronate Between DP-R206(150mg Ibandronate/24,000 IU Vitamin D3 Complex Tablet) and a 150mg Ibandronate Tablet in Healthy Adult Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Colecalciferol/ibandronic-acid (Primary) ; Ibandronic acid
- Indications Postmenopausal osteoporosis
- Focus Pharmacokinetics
- Sponsors Alvogen Korea; DreamPharma Corporation
- 13 Dec 2013 New source identified and integrated ( Clinical Research Information Service (CriS) - Republic of Korea; KCT0000191)
- 09 Sep 2011 New trial record